Literature DB >> 3964634

Radiation chorioretinopathy.

A Elmassri.   

Abstract

Three cases of postradiation retinopathy are reported. The findings are analysed. The exudates described by many authors are really infarcts of the choroid lobules. Chorioretinopathy is proposed as a better descriptive term, and three types are suggested. Diagnosis of the condition is important to spare unnecessary enucleation, as the infarcted areas may resemble a recurrence. Predisposing factors are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3964634      PMCID: PMC1041010          DOI: 10.1136/bjo.70.5.326

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Pathological study of retinoblastoma treated by radon seeds and radium disks.

Authors:  H B STALLARD
Journal:  Br J Ophthalmol       Date:  1952-05       Impact factor: 4.638

2.  Complications of cobalt plaque therapy of choroidal malanomas.

Authors:  D H Char; L I Lonn; L W Margolis
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

3.  [Ovalar syndromes. Topographic study of the choroid vascular system of the macula].

Authors:  P Amalric
Journal:  Bull Mem Soc Fr Ophtalmol       Date:  1972

4.  A clinicopathologic report on treated retinoblastoma.

Authors:  F C Blodi; R C Watzke
Journal:  Am J Ophthalmol       Date:  1971-01       Impact factor: 5.258

5.  Ocular complications after therapeutic irradiation.

Authors:  P A Macfaul; M A Bedford
Journal:  Br J Ophthalmol       Date:  1970-04       Impact factor: 4.638

6.  Post-radiation retinopathy. A fluorescence fundus angiographic study.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1970-11       Impact factor: 4.638

7.  Radiotherapy for malignant melanoma of the choroid.

Authors:  H B Stallard
Journal:  Br J Ophthalmol       Date:  1966-03       Impact factor: 4.638

  7 in total
  1 in total

1.  Choroidoretinal neovascularisation following radon seed treatment of retinoblastoma in two patients.

Authors:  D B Archer; W M Amoaku; G Kelly
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.